Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
Condition(s):Colon Cancer Stage IIILast Updated:October 27, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Colon Cancer Stage IIILast Updated:October 27, 2022Withdrawn
Condition(s):SchizophreniaLast Updated:May 15, 2012Completed
Condition(s):SchizophreniaLast Updated:April 7, 2015Terminated
Condition(s):Bipolar Disorder; Schizoaffective DisorderLast Updated:August 31, 2018Completed
Condition(s):Neonatal Abstinence SyndromeLast Updated:January 7, 2020Completed
Condition(s):Substance Use Disorders; Substance DependenceLast Updated:April 27, 2023Recruiting
Condition(s):Psychiatric Emergency; Aggression; AgitationLast Updated:June 14, 2022Completed
Condition(s):Delirium; Epileptics; NeurolepticsLast Updated:March 1, 2024Enrolling by invitation
Condition(s):Spinal Cord Injuries; Muscle SpasticityLast Updated:November 20, 2012Completed
Condition(s):SchizophreniaLast Updated:April 8, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.